PFO
RXRX icon

Pathstone Family Office’s Recursion Pharmaceuticals RXRX Stock Holding History

Pathstone Family Office’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		$93.3K Buy
+12,196
New +$93.3K ﹤0.01% 1589